Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/14/2017 02/15/2017 02/16/2017 02/17/2017 02/21/2017 Date
81.06(c) 83.255(c) 81.39(c) 81.89(c) 79.9(c) Last
1 063 456 1 346 137 904 106 632 647 881 546 Volume
+1.05% +2.71% -2.24% +0.61% -2.43% Change
More quotes
Financials ($)
Sales 2016 571 M
EBIT 2016 -65,6 M
Net income 2016 -65,6 M
Debt 2016 10,6 M
Yield 2016 -
Sales 2017 743 M
EBIT 2017 -23,8 M
Net income 2017 -21,5 M
Debt 2017 18,5 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 11,9x
EV / Sales2017 9,12x
Capitalization 6 753 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
02/21 DEXCOM INC : Change in Directors or Principal Officers (form 8-K)
01/27 DEXCOM : Launches Dexcom CLARITY® Diabetes Management Solution in EMEA
01/24 DEXCOM : announces publication of key study in the Journal of the American Medic..
01/23 DEXCOM SCHEDULES FOURTH QUARTER AND : 30 p.m. Eastern Time
01/20 INSIDER TRADING ACTIVITY DEXCOM INC. : DXCM) – CEO Sold 10,000 shares of S..
01/13 JPMorgan Chase, Pandora, DexCom climb and GameStop skids
01/13 DEXCOM : Centers for Medicare & Medicaid Services (CMS) Classify Therapeutic Con..
01/11 DEXCOM : The launch of Dexcom Canada will reshape how Canadians living with diab..
01/10 DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
01/10 DEXCOM : Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter an..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/21DJMEDTRONIC : Earnings Fall, Sales Rise -- Update
02/21 MEDTRONIC : sales, profit beat estimates; shares rise
02/21DJMEDTRONIC : Earnings Fall, Sales Rise
02/16 STRAUMANN : on hunt for 3D printer partner, could take stake - CEO
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/21BRIEF-Dexcom says chief financial officer to resign, effective as of April 1 .. 
02/18DexCom's buy rating reiterated at B. Riley. $94.00 PT.  
02/17Allianz Asset Management AG Acquires 173,258 Shares of DexCom, Inc. $DXCM  
02/17DexCom Diamond 2 Results Positive, Or At Least Not As Bad As Expected  
02/17DexCom's neutral rating reiterated at Robert W. Baird. $79.00 PT.  
More tweets
Qtime:23
News from SeekingAlpha
02/21 DexCom finance chief bids adieu
02/10 NIH Trials Set Up Artificial Pancreas Market Battle
02/06 DEXCOM : Spearhead Of A New Disruptive Technology In Diabetes
02/01 Lean Long-Term Growth Portfolio - January 2017 Update
01/31 Movers And Shakers In Diabetes Management - Where Will Medtech In 2017 Take U..
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 87,0 $
Spread / Average Target 8,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terry H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Jess Roper Chief Financial Officer & Senior Vice President
Jorge A. Valdes Chief Technology Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.33.84%6 753
MEDTRONIC PLC13.10%110 613
BAXTER INTERNATIONAL I..12.67%27 174
ZIMMER BIOMET HOLDINGS..13.54%23 469
C R BARD INC8.27%17 521
HOYA CORPORATION3.11%17 432
More Results